Bhatt R V, Pachauri S, Koshy E, Chauhan L, Mulgaonkar V
Int J Gynaecol Obstet. 1978;16(3):254-8. doi: 10.1002/j.1879-3479.1978.tb00438.x.
This study was conducted in Baroda, India, to evaluate and compare the safety and effectiveness of intraamniotic prostaglandin F2alpha (PGF2alpha) and 20% saline augmented with intravenous oxytocin for terminating 200 pregnancies of 14 to 20 weeks' gestation. While there was no method failure among the group treated with saline, ten method failures were reported for patients treated with the PGF2alpha. The rate of incomplete abortions was significantly lower for the group treated with saline (19.4%) than it was for the group treated with the PGF2alpha (33.7%). The administration of oxytocin after fetal expulsion did not reduce the rate of incomplete abortion. The mean instillation-to-abortion time was significantly lower with saline than with PGF2alpha. The incidence of gastrointestinal side effects and excessive bleeding (less than 200 ml) during the procedure was significantly higher for patients treated with PGF2alpha than for those treated with saline.
本研究在印度巴罗达进行,旨在评估和比较羊膜腔内注射前列腺素F2α(PGF2α)和静脉滴注催产素并用20%盐水引产14至20周妊娠的200例孕妇的安全性和有效性。使用盐水治疗的组中未出现方法失败情况,而使用PGF2α治疗的患者报告有10例方法失败。盐水治疗组的不全流产率(19.4%)显著低于PGF2α治疗组(33.7%)。胎儿娩出后使用催产素并未降低不全流产率。盐水引产的平均滴注至流产时间显著短于PGF2α引产。PGF2α治疗的患者术中胃肠道副作用和出血过多(少于200毫升)的发生率显著高于盐水治疗的患者。